BADIAGA (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)
Welcome to the PulseAid listing for the BADIAGA drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
NON-PROPRIETARY NAME: | BADIAGA |
SUBSTANCE NAME: | SPONGILLA LACUSTRIS |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2015-12-30 |
END MARKETING DATE: | 0000-00-00 |
BADIAGA HUMAN OTC DRUG Details:
Item Description | BADIAGA from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
LABELER NAME: | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2([hp_X]/1) |
START MARKETING DATE: | 2015-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 15631-0532_41e661bd-1448-4d82-9e58-fc1d2cdba360 |
PRODUCT NDC: | 15631-0532 |
APPLICATION NUMBER: | |
Other SPONGILLA LACUSTRIS Pharmaceutical Manufacturers / Labelers: